Biosynthesized silver nanoparticles: a step forward for cancer theranostics?
Author:
Affiliation:
1. Biomaterials Group, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad – 500007, India
2. Academy of Scientific and Innovative Research (AcSIR) Anusandhan Bhavan, 2 Rafi Marg, New Delhi –110 001, India
Publisher
Future Medicine Ltd
Subject
Development,General Materials Science,Biomedical Engineering,Medicine (miscellaneous),Bioengineering
Link
https://www.futuremedicine.com/doi/pdf/10.2217/nnm.14.89
Reference21 articles.
1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
2. BCC Research. The global market for cancer therapies will be expected to increase over $110.6 billion by 2013. www.bccresearch.com/pressroom/hlc/global-market-cancer-therapies-expected-increase-$110.6-billion-2013
3. In vivo human time-exposure study of orally dosed commercial silver nanoparticles
4. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Cited by 75 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Flavonoids as promising molecules in the cancer therapy: An insight;Current Research in Pharmacology and Drug Discovery;2024
2. Hyaluronic acid-functionalized gold nanoparticles as a cancer diagnostic probe for targeted bioimaging applications;Microchemical Journal;2023-10
3. Advancement in Biopolymer Assisted Cancer Theranostics;ACS Applied Bio Materials;2023-09-12
4. Plant-derived nanomaterials (PDNM): a review on pharmacological potentials against pathogenic microbes, antimicrobial resistance (AMR) and some metabolic diseases;3 Biotech;2023-08-04
5. Natural therapeutics for cancer treatment: success, challenges, and prospect;Journal of Bio-X Research;2023-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3